ULTRASTRUCTURAL MANIFESTATIONS OF THE PROTECTIVE EFFECT OF SUCCINIC ACID, SODIUM OXYBUTYRATE AND QUERCETIN ON THE MYOCARDIUM UNDER THE CONDITIONS OF EXPERIMENTAL MODELING OF HEART FAILURE

Authors

  • K. O. Herasymiuk I. Horbachevsky Ternopil National Medical University
  • V. V. Hnativ I. Horbachevsky Ternopil National Medical University
  • O. O. Levenets I. Horbachevsky Ternopil National Medical University

DOI:

https://doi.org/10.11603/1811-2471.2024.v.i1.14526

Keywords:

myocardial dystrophy, correction, quercetin, succinic acid, sodium oxybutyrate

Abstract

SUMMARY. Pathology of the cardiovascular system today is one of the main causes of mortality and disability of the population in most countries of the world. Therefore, the researches of recent years are precisely aimed at the search for effective means of preventing of irreversible necrobiotic processes in the myocardium.

The aim – to establish ultrastructural features of the protective effect of succinic acid, sodium oxybutyrate and quercetin in the simulation of myocardial dystrophy.

Material and Methods. Experiments were carried out on white laboratory inbred young rats. Modeling of myocardial damage with the development of signs of cardiovascular failure was carried out according to a known method of O. O. Markova. Correction of violations was carried out by using succinic acid, sodium oxybutyrate and quercetin.

Results. When simulating adrenaline-induced myocardiodystrophy, quite clear signs of disruption of both hemomicrocirculation and cardiomyocyte trophicity were noted already after 2 hours from the onset of the experiment. After 24 hours, expressed destructive changes in the elements of the parenchyma, which developed on the background of noticeable hemodynamic disorders in the hemomicrocirculatory channel, already came to the fore.

Corrective use of succinic acid, sodium oxybutyrate, and corvitin on the background of adrenaline-induced myocardial dystrophy prevents the development of structural damage to the myocardium in the first 2 hours and significantly reduces their development during the next day. Moreover, the positive effect was observed both in the hemomicrocirculatory channel and in the morphofunctional condition of the cardiomyocytes themselves.

Conclusions. A cardiotoxic dose of adrenaline causes dystrophic changes in cardiomyocytes, in the development of which disorders of coronary circulation play an important role and which progressively increase from 2 to 24 hours of observation after the introduction of the drug. Each of the agents used: succinic acid, sodium oxybutyrate, and quercetin has a cardioprotective effect due to a positive regulatory effect on coronary blood circulation and a corresponding reduction in the degree of myocardial hypoxia. Quercetin has more expressed angioprotective properties compared to succinic acid and sodium oxybutyrate.

References

Shevchuk, M.M. (2023). Ultrastrukturni osoblyvosti budovy sercya biloho shchura v normi [Ultrastructural features of the structure of the heart of a white rat in the norm]. Zdobutky klinichnoyi i eksperymentalnoyi medytsyny – Achievements of clinical and experimental medicine, 4, 177-181 [in Ukrainian].

Sirenko, Yu.M. (2022). Stan problemy sercevo-sudynnoyi zakhvoriuvanosti ta smertnosti v Ukrayini [State of the problem of cardiovascular morbidity and mortality in Ukraine]. Liky Ukrayiny – Medicines of Ukraine, 2(258), 11-14 [in Ukrainian].

Dzyuba, D.O., Zhurovska, Yu.M., & Loskutov, O.A. (2017). Pytannya anesteziolohichnoho zabezpechennya v intervenciyniy kardiolohiyi [The issue of anesthetic support in interventional cardiology]. Medycyna nevidkladnykh staniv – Medicine of emergency conditions, 1(80), 125-128 [in Ukrainian].

Lynda, O.S., Pelykh, V.Ye., Fira, L.S., & Denefil, O.V. (2019). Porivnyalnyi analiz kardioprotektornykh vlastyvostei korvitynu ta sukhoho ekstraktu z khosty lancetolystoyi lystya za umov adrenalinovoho ushkodzhennya sertsya [Comparative analysis of the cardioprotective properties of corvitin and dry extract from hosta lancifolia in conditions of adrenaline damage to the heart]. Medychna ta klinichna khimiya – Medical and clinical chemistry, 4(21), 44-53 [in Ukrainian].

Slabyi, O.B. (2016). Yaderno-cytoplazmatychni vidnoshennya u kardiomiocytax ta endoteliocytax peredserd lehenevoho sertsya [Nuclear-cytoplasmic relations in cardiomyocytes and endotheliocytes of the atria of the pulmonary heart]. Zdobutky klinichnoyi i eksperymentalnoyi medytsyny – Achievements of clinical and experimental medicine, 4, 103-106 [in Ukrainian].

Markova, O.O. (1998). Miokardiodystrofiya i reaktyvnist organizmu [Myocardiodystrophy and organism reactivity]. Ternopil: Ukrmedknyha [in Ukrainian].

Chebotar, L.D. (2011). Funktsionalnyi stan sertsya shchuriv v umovakh hipofunktsiyi epifizu na tli rozvytku adrenalinovoyi miokardiodystrofiyi [The functional condition of the heart of rats at hypofunction of the pineal gland on the background of the development of adrenaline myocardiodystrophy]. Aktualni problemy suchasnoyi medycyny: Visnyk ukrayinskoyi medychnoyi stomatologichnoyi akademiyi – Actual problems of modern medicine: Bulletin of the Ukrainian Medical Stomatological Academy, 2(11), 103-106 [in Ukrainian].

Sarkysov, D.S., Paltsev, M.A., & Khytrov, N.K. (1997). Obshchaya patologiya cheloveka [General human pathology]. Moscow.: Medycyna [in Russian].

Kosharnyi, V.V., Rutgajzer, V.G., Abdul-Ogly L.V., Kushnariova, K.A., Bondarenko, N.S., & Tverdokhlib, I.V. (2019). Ultrastruktura mitokhondrialnoho aparatu kardiomiocytiv livoho shlunochka sertsya shchuriv pislya diyi riznykh ekspozytsiy elektromagnitnoho oprominennya za umov hipotyrozu [Ultrastructure of the mitochondrial apparatus of cardiomyocytes of the left ventricle of the heart of rats after various exposures to electromagnetic radiation in conditions of hypothyroidism]. Morpholohia – Morphology, 13(4), 16-23 [in Ukrainian].

Pokotylo, P.B. (2014). Zminy mitoxondrialnoho aparatu kardiomiocytiv shchuriv na rannikh terminakh khronichnoyi opioyidnoyi intoksykatsiyi [Changes in the mitochondrial apparatus of rat cardiomyocytes in the early stages of chronic opioid intoxication]. Svit medycyny ta biolohiyi – World of medicine and biology, 3(45), 141-144 [in Ukrainian].

Kaminskyi, R.F., Stechenko, L.O., Dovhan, R.S., & Chaikovskyi, Yu.B. (2010). Porivnyalnyi analiz ultrastruktury miokarda shchuriv, likovanykh unitiolom ta kvercetynom pry rtutnomu otruyenni [Comparative analysis of the ultrastructure of the myocardium of rats treated with unitiol and quercetin in case of mercury poisoning], Svit medytsyny ta biolohiyi – World of Medicine and Biology, 4, 117-120 [in Ukrainian].

Shysh, A.M., Maksymchuk, O.V., Rozova, K.V., Frantsuzova, S.B., Chashhyn, M.O., & Moibenko, O.O. (2014). Ultrastrukturni zminy miokarda shchuriv pry eksperymentalnomu tsukrovomu diabeti ta mozhlyvosti yikh korekciyi preparatamy metabolitnoho typu diyi [Ultrastructural changes of the myocardium of rats with experimental diabetes and the possibility of their correction with drugs of the metabolic type of action]. Visnyk morfolohiyi – Herald of morphology, 2(20), 334-339.13 [in Ukrainian].

Moibenko, A.A. (2012). Bioflavonoidy kak organoprotektory kvarcetin, korvitin, kvertin [Bioflavonoids as organoprotectors quartzetin, corvitin, quertin]. Kyiv: Naukova dumka [in Russian].

Mulvihill, E.E., & Huff, M.W. (2010). Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can. J. Cardiol., 26, 17A-21A.

Zhukovska, A. (2014). Heart protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy. Mol. Cell. Biochem., 389(1-2), 219-227.

Zupanets, I.A., Holubovska, O.A., Shkurba, A.V., Shebeko, S.K., & Shalamai, A.S. (2020). Perspektyvy vyvchennya zastosuvannya preparativ kvercetynu v likuvanni COVID-19 [Prospects of studying the use of quercetin preparations in the treatment of COVID-19]. Ukr. med. chasopys – Ukr. med. magazine, 2(1) (136), III/IV [in Ukrainian].

Orlov, Yu.P., & Hovorova, N.V. (2014). Rol sukcinatov pri kriticheskikh sostoyaniyakh [The role of succinates in critical conditions]. Obshchaya reanimaciya – General resuscitation, 10(6), 65-78 [in Russian].

Palchevskaya, T. (2020). Primenieniye yantarnoi kisloty i natriya sukcynata v farmaciyi [Application of succinic acid and sodium succinate in pharmacy]. Conference: Science, society, education: topical issues and development prospects. Abstracts of the 5th International scientific and practical conference. SPC “Sci-conf.com.ua”. Kharkiv [in Russian].

Dzyuba, D.O., & Nedashkivskyi, S.M. (2013). Oksybutyrat natriyu: Znaiomyi neznaiomets [Sodium oxybutyrate: A familiar stranger]. Gostri ta nevidkladni stany u praktytsi likarya – Acute and urgent conditions in the practice of a doctor, 4-5(36) [in Ukrainian].

Published

2024-03-28

How to Cite

Herasymiuk, K. O., Hnativ, V. V., & Levenets, O. O. (2024). ULTRASTRUCTURAL MANIFESTATIONS OF THE PROTECTIVE EFFECT OF SUCCINIC ACID, SODIUM OXYBUTYRATE AND QUERCETIN ON THE MYOCARDIUM UNDER THE CONDITIONS OF EXPERIMENTAL MODELING OF HEART FAILURE. Achievements of Clinical and Experimental Medicine, (1), 62–69. https://doi.org/10.11603/1811-2471.2024.v.i1.14526

Issue

Section

Оригінальні дослідження